Kathy Ellarene Novella Proctor, MS, BSN, RN- CCM | |
182 E Linden Ave, Dumont, NJ 07628-1916 | |
(646) 401-3115 | |
(201) 330-4645 |
Full Name | Kathy Ellarene Novella Proctor |
---|---|
Gender | Female |
Speciality | Nutritionist - Nutrition, Education |
Location | 182 E Linden Ave, Dumont, New Jersey |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1962121251 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Kathy Ellarene Novella Proctor, MS, BSN, RN- CCM 182 E Linden Ave, Dumont, NJ 07628-1916 Ph: (646) 401-3115 | Kathy Ellarene Novella Proctor, MS, BSN, RN- CCM 182 E Linden Ave, Dumont, NJ 07628-1916 Ph: (646) 401-3115 |
News Archive
Mayo researchers collaborating with investigators at the University of Iowa, University of Connecticut and New York University (NYU) have discovered a molecular mechanism that controls energy expenditure in muscles and helps determine body weight. Researchers say this could lead to a new medical approach in treating obesity.
There are two problems that pathologists face today. The first is, that a pathologist's diagnosis using tissue sections is becoming more complex. There are many more biomarkers, and clinicians now ask for a more precise diagnosis. Secondly, the number of pathologists worldwide is declining every day, as the profession is often overlooked in favor of other specializations.
Allied Healthcare International Inc. (AIM: AHI) (http://www.alliedhealthcare.com), a leading provider of flexible healthcare staffing services in the United Kingdom, has secured a three-year contract with the London Borough of Redbridge Council in the United Kingdom.
Former NFL players who had repeated head injuries may not have significant problems with motor functions later in life, according to a preliminary study released today that will be presented at the American Academy of Neurology's 69th Annual Meeting in Boston, April 22 to 28, 2017.
BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, has presented efficacy, safety and biodistribution results on its new biotherapy AMEP™ for advanced and metastatic melanoma at the 13th Annual Meeting of the American Society of Gene and Cell Therapy in Washington, DC (May 17 - 22, 2010).
› Verified 4 days ago